NfL as a Potential Biomarker in ATTRv Amyloidosis - European Medical Journal

NfL as a Potential Biomarker in ATTRv Amyloidosis

Neurology
Download PDF

Infographic: NfL as a Potential Biomarker in ATTRv Amyloidosis

Publication of this infographic was supported and reviewed by Alnylam Pharmaceuticals.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given